Laboratoires Leurquin Mediolanum
1 clinical trials · Sponsor
◉ Watch Laboratoires Leurquin Mediolanum
| Record | Firm | Date |
|---|---|---|
| A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer (NCT02293707) | Laboratoires Leurquin Mediolanum | 2014-11-01 |
Track Laboratoires Leurquin Mediolanum automatically
Every clearance here is in the API, with alerts when new ones post.